Isabelle Jalenques1, Diane Cyrille1, Philippe Derost2, Andreas Hartmann3, Sophie Lauron1, Clara Jameux1, Urbain Tauveron-Jalenques1, Candy Guiguet-Auclair4, Fabien Rondepierre1. 1. Centre de Compétence Gilles de la Tourette, Service de Psychiatrie de l'Adulte A et Psychologie Médicale, CHU Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France. 2. Service de Neurologie, CHU Clermont-Ferrand, Clermont-Ferrand, France. 3. Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, National Reference Center for Tourette Syndrome, Paris, France. 4. Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, Clermont-Ferrand, France.
Abstract
INTRODUCTION: The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) is a self-rated disease-specific questionnaire to assess health-related quality of life of subjects with GTS. Our aim was to perform the cross-cultural adaptation of the GTS-QOL into French and to assess its psychometric properties. METHODS: The GTS-QOL was cross-culturally adapted by conducting forward and backward translations, following international guidelines. The psychometric properties of the GTS-QOL-French were assessed in 109 participants aged 16 years and above with regard to factor structure, internal consistency, reliability and convergent validity with the MOVES (Motor tic, Obsessions and compulsions, Vocal tic Evaluation Survey) and the WHOQOL-BREF (World Health Organization Quality of Life Brief). RESULTS: Exploratory factor analysis of the GTS-QOL-French resulted in a 6-factor solution and did not replicate the original structure in four subscales. The results showed good acceptability (missing values per subscale ranging from 0% to 0.9%), good internal consistency (Cronbach's alpha ranging from 0.68 to 0.94) and good test-retest reliability (intraclass correlation coefficients ranging from 0.70 to 0.81). Convergent validity with the MOVES and WHOQOL-BREF scales showed high correlations. DISCUSSION: Our study provides evidence of the good psychometric properties of the GTS-QOL-French. The cross-cultural adaptation and validation of this specific instrument will make it possible to assess health-related quality of life in French-speaking subjects with GTS. The GTS-QOL-French could be recommended for use in future research.
INTRODUCTION: The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) is a self-rated disease-specific questionnaire to assess health-related quality of life of subjects with GTS. Our aim was to perform the cross-cultural adaptation of the GTS-QOL into French and to assess its psychometric properties. METHODS: The GTS-QOL was cross-culturally adapted by conducting forward and backward translations, following international guidelines. The psychometric properties of the GTS-QOL-French were assessed in 109 participants aged 16 years and above with regard to factor structure, internal consistency, reliability and convergent validity with the MOVES (Motor tic, Obsessions and compulsions, Vocal tic Evaluation Survey) and the WHOQOL-BREF (World Health Organization Quality of Life Brief). RESULTS: Exploratory factor analysis of the GTS-QOL-French resulted in a 6-factor solution and did not replicate the original structure in four subscales. The results showed good acceptability (missing values per subscale ranging from 0% to 0.9%), good internal consistency (Cronbach's alpha ranging from 0.68 to 0.94) and good test-retest reliability (intraclass correlation coefficients ranging from 0.70 to 0.81). Convergent validity with the MOVES and WHOQOL-BREF scales showed high correlations. DISCUSSION: Our study provides evidence of the good psychometric properties of the GTS-QOL-French. The cross-cultural adaptation and validation of this specific instrument will make it possible to assess health-related quality of life in French-speaking subjects with GTS. The GTS-QOL-French could be recommended for use in future research.
Authors: M Bullinger; J Alonso; G Apolone; A Leplège; M Sullivan; S Wood-Dauphinee; B Gandek; A Wagner; N Aaronson; P Bech; S Fukuhara; S Kaasa; J E Ware Journal: J Clin Epidemiol Date: 1998-11 Impact factor: 6.437
Authors: Davide Martino; Tamara M Pringsheim; Andrea E Cavanna; Carlo Colosimo; Andreas Hartmann; James F Leckman; Sheng Luo; Alexander Munchau; Christopher G Goetz; Glenn T Stebbins; Pablo Martinez-Martin Journal: Mov Disord Date: 2017-01-10 Impact factor: 10.338
Authors: A E Cavanna; A Schrag; D Morley; M Orth; M M Robertson; E Joyce; H D Critchley; C Selai Journal: Neurology Date: 2008-10-28 Impact factor: 9.910
Authors: Roger D Freeman; Samuel H Zinner; Kirsten R Müller-Vahl; Diane K Fast; Larry J Burd; Yukiko Kano; Aribert Rothenberger; Veit Roessner; Jacob Kerbeshian; Jeremy S Stern; Joseph Jankovic; Thomas Loughin; Piotr Janik; Gary Shady; Mary M Robertson; Anthony E Lang; Cathy Budman; Alida Magor; Ruth Bruun; Cheston M Berlin Journal: Dev Med Child Neurol Date: 2008-12-04 Impact factor: 5.449